Extended Survival in Patients With Non–Small-Cell Lung Cancer–Associated Brain Metastases in the Modern Era
Assaf Berger(Neurological Surgery), Douglas Kondziolka(Neurological Surgery), John G. Golfinos(NYU Langone Health), Joshua K. Sabari(NYU Langone Health), Erik P. Sulman(NYU Langone Health), Abraham Chachoua(New York University), Vamsidhar Velcheti(Cleveland Clinic), Kenneth Bernstein(NYU Langone Health), Elaine Shum(NYU Langone’s Laura and Isaac Perlmutter Cancer Center), Joshua S. Silverman(NYU Langone Health), Juan Diego Alzate(Neurological Surgery), Bernadine R. Donahue(Maimonides Medical Center), Reed Mullen(Neurological Surgery)
Cited by 20
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
|Nature Medicine|2018|927
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
|Nature Reviews Clinical Oncology|2021|810